Autolus Therapeutics Plc ADR
(AUTL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 09-2018 | 12-2017 | 09-2017 | |
| Sales | 2,908 | 0 | 1,407 | 0 | 1,693 |
| Gross Profit | 2,908 | N/A | 1,407 | 1,690 | 1,693 |
| Operating Expenses | 148,972 | 0 | 58,940 | 22,790 | 25,111 |
| Operating Income | -146,064 | N/A | -57,533 | -22,790 | -23,418 |
| Other Income | 7,056 | 0 | 5,502 | 0 | 38 |
| Pre-tax Income | -139,008 | 0 | -52,031 | -22,790 | -23,380 |
| Income Tax | -15,159 | N/A | -7,280 | N/A | -3,653 |
| Net Income Continuous | -123,849 | N/A | -44,751 | -22,790 | -19,727 |
| Net Income | $-123,849 | $N/A | $-44,751 | $-44,751 | $-19,727 |
| EPS Basic Total Ops | -2.88 | N/A | -1.42 | N/A | -1.43 |
| EPS Basic Continuous Ops | -2.88 | N/A | -1.42 | N/A | -1.43 |
| EPS Diluted Total Ops | -2.88 | N/A | -1.42 | N/A | -1.43 |
| EPS Diluted Continuous Ops | -2.88 | N/A | -1.42 | N/A | -1.43 |
| EPS Diluted Before Non-Recurring Items | -2.88 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-141,453 | $N/A | $-55,824 | $-21,790 | $-22,409 |